Forus Health focuses on affordable ophthalmology technology designed for use by minimally trained technicians. Its portfolio product, 3nethra, is a pre-screening ophthalmology device and the company says it has sold 200 devices in India. Forus was founded in 2010 and operates an R&D facility in Bangalore. The company plans to develop new products from that R&D facility and to scale through strengthened supply chain and sales networks. Financially, Forus has completed a Series B round and previously raised capital in 2012. The business positions itself as a domestic alternative to imported medical equipment makers. Forus Health Pvt. Ltd. is a Bangalore-based affordable medical technology and solutions company focused on ophthalmology. Its core product, 3nethra, is a portable, low-cost, non-mydriatic, non-invasive pre-screening ophthalmology device that can detect cataract, glaucoma, diabetic retina, refraction and cornea problems. 3nethra can be operated by a minimally trained technician and is designed for deployment in remote areas. The company is led by President & CTO Dr. Shyam Vasudeva Rao, PhD., and CEO K Chandrasekhar. Forus has raised $5M in Series A funding from Accel Partners and IDG Ventures India. The company intends to use the funding to drive manufacturing and sales of 3nethra and to accelerate research on 3nethra and other devices.

Total raised

$13M

Funding rounds

2

Latest round

Series B

Latest activity

Jan 2014